INMB - INmune Bio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INMB is currently covered by 1 analysts with an average price target of $16.7. This is a potential upside of $8.96 (115.76%) from yesterday's end of day stock price of $7.74.

INmune Bio's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of INMB is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 161 days.

Highest price target for INMB is $23, Lowest price target is $23, average price target is $23.

Most recent stock forecast was given by GEORGE FARMER from SCOTIABANK on 11-Feb-2025. First documented stock forecast 29-Jan-2021.

Best performing analysts who are covering INMB - INmune Bio:

Chad Mabry Mayank Mamtani Thomas Shrader George Farmer

Currently out of the existing stock ratings of INMB, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$23

$14.97 (186.43%)

$22

20 days ago
(11-Feb-2025)

0/2 (0%)

$14.75 (178.79%)

Hold

$7

$-2.18 (-23.75%)

$20

2 years 9 months 7 days ago
(24-May-2022)

1/2 (50%)

$1.52 (27.74%)

13

Buy

$14

$4.82 (52.51%)

$31

2 years 9 months 7 days ago
(24-May-2022)

1/2 (50%)

$8.52 (155.47%)

631

Buy

$34

$23.48 (223.19%)

$29

3 years 7 months 18 days ago
(14-Jul-2021)

0/2 (0%)

$11.04 (48.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INMB (INmune Bio) average time for price targets to be met?

On average it took 161 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on INMB (INmune Bio) with a proven track record?

CHAD MABRY

Which analyst has the current lower performing score on INMB (INmune Bio) with a proven track record?

GEORGE FARMER

Which analyst has the most public recommendations on INMB (INmune Bio)?

Chad Mabry has 14 price targets and 8 ratings on INMB

Which analyst is the currently most bullish on INMB (INmune Bio)?

Chad Mabry with highest potential upside - $23.48

Which analyst is the currently most reserved on INMB (INmune Bio)?

Mayank Mamtani with lowest potential downside - -$2.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?